Biological Age Tests Compared: What Six Tests Actually Measure

Why Biological Age Tests Give Different Numbers, and Why That Is the Point

If you have looked into biological age testing, you have probably noticed that the market offers a confusing range of options. What is less obvious is that these tests are not all measuring the same thing. A telomere test, an epigenetic methylation test, and a glycan-based inflammation test each read a different biological signal, use a different analytical method, and report a number that represents a different layer of the aging process.

That means a single person could take all six tests reviewed here and receive six different biological age numbers. That is not a sign that the tests are broken. It reflects the fact that aging is not one process. It is many overlapping processes, and each test category captures a different slice.

For this analysis, we reviewed the publicly available product and methodology pages for six consumer biological age tests as of March 2026. The six tests span three distinct method categories: telomere length analysis, DNA methylation, and IgG glycosylation. The goal is not to name a winner. It is to help readers understand what each method actually measures, where the products diverge in report depth and transparency, and how to choose based on what they want to learn. For readers comparing options available through NuGeneLabs health tests, this method-first framework is the most useful place to start.

The fact that these tests use fundamentally different biomarkers is the single most important thing to understand before buying one. Choosing the right test starts with choosing the right method for your question.

Three Methods, Three Layers of Aging

The six tests in this comparison fall into three categories based on the biological signal they analyze. Understanding these categories matters more than comparing individual products, because the method determines what kind of aging information you receive. The planning for this article explicitly recommended centering the piece around method buckets first and using a grouped visual to show that distinction at a glance.

Telomere Length

Telomeres are protective caps at the ends of chromosomes that shorten as cells divide over time. Measuring their length provides a snapshot of cellular aging at the chromosomal level.

One test in this review uses this approach: TeloTest from Fagron Genomics. It analyzes telomere length from a cheek swab using a qPCR-style measurement and infers a biological age estimate from the result.

Compared with the methylation-based tests reviewed below, the telomere approach captures a single biological signal rather than patterns across hundreds or thousands of markers. Based on how these products position themselves publicly, telomere testing is best understood as a focused, low-barrier starting point rather than a multi-dimensional aging assessment. For consumers who want a simple, non-blood biological age number, it serves a clear purpose.

DNA Methylation and Epigenetic Clocks

Four of the six tests in this review use DNA methylation as their core method. DNA methylation refers to chemical modifications on the genome that change with age and are influenced by lifestyle, environment, and health status. By analyzing patterns across many methylation sites, these tests estimate biological age through what are commonly called epigenetic clocks.

The four methylation-based tests differ in sample type, clock model, and report depth. myDNAge uses a finger-prick blood sample and explicitly references Horvath’s epigenetic aging clock. TallyAge uses a cheek swab and positions itself around repeat measurement. TruAge uses a finger-prick dried blood spot and goes beyond a single age number to include speed of aging and other longevity metrics. Index uses saliva and reports the broadest set of outputs among the tests reviewed, including overall biological age, cumulative rate of aging, and nine system-level ages.

The reviewed product pages show this range clearly: some methylation tests center on a single primary output, while others layer in additional dimensions. Understanding where a given test sits on that spectrum is one of the most practical things a consumer can do before purchasing.

Glycan Analysis and Inflammaging

The sixth test in this review, GlycanAge, uses an entirely different biological signal. Rather than measuring telomere length or DNA methylation, GlycanAge analyzes IgG glycosylation, the sugar structures attached to immunoglobulin G antibodies. These glycan patterns are used to assess chronic inflammation and produce a biological age estimate framed around inflammaging.

GlycanAge uses a finger-prick dried blood card and positions itself around lifestyle responsiveness. Its public materials emphasize that the test shows how the body responds to stress, lifestyle changes, and interventions. This is a meaningfully different positioning from the methylation tests, which generally frame their outputs around a more stable age estimate. GlycanAge also returns results in about two to three weeks, the fastest turnaround among the tests reviewed.

Because GlycanAge measures a fundamentally different biological signal, its result should not be treated as interchangeable with a methylation-based biological age number. The public product pages note the inflammaging framing, but do not explicitly explain how a glycan-based age relates to results from an epigenetic clock.

Six Tests Side by Side

The table below summarizes each test across key criteria drawn directly from the publicly available product and methodology pages reviewed for this analysis. All cell content is sourced from those pages. Where a data point was not clearly stated on the reviewed page, it is noted accordingly. The planning for this asset identified this table as the core linkable element and recommended placing it as the anchor section of the article.

Detailed Test Profiles

What the Product Pages Do Not Make Clear

One of the most useful things about a side-by-side review is the ability to spot patterns you cannot see from a single product page. Several of those patterns involve gaps in what the public-facing pages explain.

Cross-Method Comparability Is Not Explained

Nearly every product page reviewed for this analysis lacks a clear explanation of how its biological age result compares with tests using a different method. TeloTest does not explain how a telomere-based result should be interpreted alongside a methylation-based result. TallyAge does not address how cheek-swab methylation outputs compare with blood-based clocks. Index does not clarify how saliva-based outputs compare with blood-based tests. GlycanAge’s pages may leave consumers unclear that its result is not a methylation-based age and should not be directly compared with one. This pattern was identified as one of the strongest source-pack-grounded claims in the pre-draft review.

Turnaround Times Are Inconsistently Disclosed

All six tests provide a clear turnaround estimate on their public product pages: TeloTest and TruAge at approximately two weeks or less, TallyAge at 4–6 weeks, myDNAge at 4–6 weeks, Index at approximately 6 weeks, and GlycanAge at about 2–3 weeks. For consumers deciding between tests, turnaround is a practical factor that deserves consistent disclosure.

Clock Algorithm Specificity Varies

The degree to which each test names its underlying analytical model varies considerably. myDNAge explicitly references Horvath’s epigenetic aging clock. Index references its APEX platform by name. TruAge describes large-scale DNA methylation analysis without naming specific clock models on the reviewed page. TallyAge describes an epigenetic age clock without naming a published model. TeloTest infers biological age from telomere length without naming its algorithm. GlycanAge uses a glycan-based inflammaging model distinct from the methylation-clock category entirely.

Retest Cadence Guidance Is Largely Absent

Based on our review of the public product pages, most tests do not clearly explain how often consumers should retest or what magnitude of change between tests would be considered meaningful. TallyAge is the notable exception, with retesting cadence built into its product framing. For the other five, consumers are left to decide on their own when to retest, which limits the practical value of the test as a longitudinal tracking tool. The pre-draft specifically preserved this as an editorial observation rather than a hard scientific claim.

Sample Type Differences Are Not Addressed

Among the four methylation-based tests, sample types vary: two use cheek swab or saliva, and two use finger-prick blood. None of the reviewed product pages explain how sample type might affect comparability across tests. This is a consumer-facing gap worth noting because people may take one test now and a different test later, then assume the two outputs are directly comparable. The planning notes flagged this gap as source-pack-grounded while treating the deeper tissue-specific science as optional future citation material.

Choosing by What You Want to Know

Rather than ranking these tests from best to worst, the more useful framework is to match a test’s method and output style to the question you are trying to answer. The planning and final draft both positioned this section as a use-case framework, not a product-ranking section.

What This Comparison Cannot Tell You

This analysis is built on publicly available product and methodology pages reviewed as of March 2026. It does not include head-to-head accuracy benchmarking, clinical validation depth analysis, or proprietary algorithm details not disclosed on the reviewed pages. Pricing was excluded because it varies by subscription model, region, and promotional timing and would be outdated quickly. Post-purchase user experience, app quality, and report readability beyond what is shown on public pages are also outside scope. If you want a broader view of how testing fits into a longer-term strategy, see our guide to healthy aging.

The biological age testing category is still maturing. New clock models, new sample types, new reporting frameworks, and new validation studies appear regularly. Any comparison like this one is a snapshot, not a permanent verdict. Consumers should treat their results as one data point within a broader picture of their health, interpreted in context and ideally discussed with a qualified practitioner. For a broader practical overview, our Longevity & Anti-Aging FAQ covers many of the foundational questions people ask before they start testing.

Methodology

Related NuGeneLabs Reading